This trial wanted to see if the blood thinning drug dalteparin (Fragmin) could reduce the number of blood clots people had during treatment for lung cancer. And to find out if it could help stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback